Difference between revisions of "Maehara O, et al. Neoplasia (2019) cited as Ref 398 in DOI: 10.1038/s41392-020-0110-5 (Q9661)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 21, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: title (P93): Metformin regulates the expression of CD133 through the AMPK-CEBPbeta pathway in hepatocellular carcinoma cell lines, #quickstatements; #temporary_batch_1590010982689) |
||
| Property / title | |||
| + | Metformin regulates the expression of CD133 through the AMPK-CEBPbeta pathway in hepatocellular carcinoma cell lines (English) | ||
| Property / title: Metformin regulates the expression of CD133 through the AMPK-CEBPbeta pathway in hepatocellular carcinoma cell lines (English) / rank | |||
| + | Normal rank | ||
Revision as of 22:01, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Maehara O, et al. Neoplasia (2019) cited as Ref 398 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Maehara O
0 references
2019
0 references
Neoplasia
0 references
21
0 references
Metformin regulates the expression of CD133 through the AMPK-CEBPbeta pathway in hepatocellular carcinoma cell lines (English)
0 references
